Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release May 05 2026

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for Calcium Gluconate Injection USP".

View Attachment

Earlier from Caplin Point Laboratories

All Caplin Point Laboratories news releases